Cargando…

Environmental scan of anal cancer screening practices: worldwide survey results

Anal squamous cell carcinoma is rare in the general population but certain populations, such as persons with HIV, are at increased risk. High-risk populations can be screened for anal cancer using strategies similar to those used for cervical cancer. However, little is known about the use of such sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Jigisha, Salit, Irving E, Berry, Michael J, de Pokomandy, Alexandra, Nathan, Mayura, Fishman, Fred, Palefsky, Joel, Tinmouth, Jill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303174/
https://www.ncbi.nlm.nih.gov/pubmed/24740973
http://dx.doi.org/10.1002/cam4.250
_version_ 1782353901623705600
author Patel, Jigisha
Salit, Irving E
Berry, Michael J
de Pokomandy, Alexandra
Nathan, Mayura
Fishman, Fred
Palefsky, Joel
Tinmouth, Jill
author_facet Patel, Jigisha
Salit, Irving E
Berry, Michael J
de Pokomandy, Alexandra
Nathan, Mayura
Fishman, Fred
Palefsky, Joel
Tinmouth, Jill
author_sort Patel, Jigisha
collection PubMed
description Anal squamous cell carcinoma is rare in the general population but certain populations, such as persons with HIV, are at increased risk. High-risk populations can be screened for anal cancer using strategies similar to those used for cervical cancer. However, little is known about the use of such screening practices across jurisdictions. Data were collected using an online survey. Health care professionals currently providing anal cancer screening services were invited to complete the survey via email and/or fax. Information was collected on populations screened, services and treatments offered, and personnel. Over 300 invitations were sent; 82 providers from 80 clinics around the world completed the survey. Fourteen clinics have each examined more than 1000 patients. Over a third of clinics do not restrict access to screening; in the rest, eligibility is most commonly based on HIV status and abnormal anal cytology results. Fifty-three percent of clinics require abnormal anal cytology prior to performing high-resolution anoscopy (HRA) in asymptomatic patients. Almost all clinics offer both anal cytology and HRA. Internal high-grade anal intraepithelial neoplasia (AIN) is most often treated with infrared coagulation (61%), whereas external high-grade AIN is most commonly treated with imiquimod (49%). Most procedures are performed by physicians, followed by nurse practitioners. Our study is the first description of global anal cancer screening practices. Our findings may be used to inform practice and health policy in jurisdictions considering anal cancer screening.
format Online
Article
Text
id pubmed-4303174
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-43031742015-01-22 Environmental scan of anal cancer screening practices: worldwide survey results Patel, Jigisha Salit, Irving E Berry, Michael J de Pokomandy, Alexandra Nathan, Mayura Fishman, Fred Palefsky, Joel Tinmouth, Jill Cancer Med Cancer Prevention Anal squamous cell carcinoma is rare in the general population but certain populations, such as persons with HIV, are at increased risk. High-risk populations can be screened for anal cancer using strategies similar to those used for cervical cancer. However, little is known about the use of such screening practices across jurisdictions. Data were collected using an online survey. Health care professionals currently providing anal cancer screening services were invited to complete the survey via email and/or fax. Information was collected on populations screened, services and treatments offered, and personnel. Over 300 invitations were sent; 82 providers from 80 clinics around the world completed the survey. Fourteen clinics have each examined more than 1000 patients. Over a third of clinics do not restrict access to screening; in the rest, eligibility is most commonly based on HIV status and abnormal anal cytology results. Fifty-three percent of clinics require abnormal anal cytology prior to performing high-resolution anoscopy (HRA) in asymptomatic patients. Almost all clinics offer both anal cytology and HRA. Internal high-grade anal intraepithelial neoplasia (AIN) is most often treated with infrared coagulation (61%), whereas external high-grade AIN is most commonly treated with imiquimod (49%). Most procedures are performed by physicians, followed by nurse practitioners. Our study is the first description of global anal cancer screening practices. Our findings may be used to inform practice and health policy in jurisdictions considering anal cancer screening. BlackWell Publishing Ltd 2014-08 2014-04-16 /pmc/articles/PMC4303174/ /pubmed/24740973 http://dx.doi.org/10.1002/cam4.250 Text en © 2014 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Prevention
Patel, Jigisha
Salit, Irving E
Berry, Michael J
de Pokomandy, Alexandra
Nathan, Mayura
Fishman, Fred
Palefsky, Joel
Tinmouth, Jill
Environmental scan of anal cancer screening practices: worldwide survey results
title Environmental scan of anal cancer screening practices: worldwide survey results
title_full Environmental scan of anal cancer screening practices: worldwide survey results
title_fullStr Environmental scan of anal cancer screening practices: worldwide survey results
title_full_unstemmed Environmental scan of anal cancer screening practices: worldwide survey results
title_short Environmental scan of anal cancer screening practices: worldwide survey results
title_sort environmental scan of anal cancer screening practices: worldwide survey results
topic Cancer Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303174/
https://www.ncbi.nlm.nih.gov/pubmed/24740973
http://dx.doi.org/10.1002/cam4.250
work_keys_str_mv AT pateljigisha environmentalscanofanalcancerscreeningpracticesworldwidesurveyresults
AT salitirvinge environmentalscanofanalcancerscreeningpracticesworldwidesurveyresults
AT berrymichaelj environmentalscanofanalcancerscreeningpracticesworldwidesurveyresults
AT depokomandyalexandra environmentalscanofanalcancerscreeningpracticesworldwidesurveyresults
AT nathanmayura environmentalscanofanalcancerscreeningpracticesworldwidesurveyresults
AT fishmanfred environmentalscanofanalcancerscreeningpracticesworldwidesurveyresults
AT palefskyjoel environmentalscanofanalcancerscreeningpracticesworldwidesurveyresults
AT tinmouthjill environmentalscanofanalcancerscreeningpracticesworldwidesurveyresults